enVVeno Medical (NVNO) Cash from Financing Activities (2017 - 2025)

enVVeno Medical's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $782000.0 for Q4 2025.

• In Q4 2025, Cash from Financing Activities changed N/A year-over-year to $782000.0; the TTM figure through Dec 2025 stood at $14.4 million (up 5.4% YoY), while the FY2025 annual figure was $1.0 million, down 92.5% from the prior year.
• Cash from Financing Activities was $782000.0 for Q4 2025 at enVVeno Medical, down from $13.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $38.4 million in Q1 2021 to a low of -$4000.0 in Q4 2021.
• Historically, Cash from Financing Activities has averaged $12.0 million across 3 years, with a median of $7.2 million in 2024.
• Biggest YoY gain for Cash from Financing Activities was 6627.2% in 2021; the steepest drop was 100.06% in 2021.
• A 3-year view of Cash from Financing Activities shows it stood at -$4000.0 in 2021, then soared by 339875.0% to $13.6 million in 2024, then slumped by 94.25% to $782000.0 in 2025.
• The last three Cash from Financing Activities figures came in at $782000.0 (Q4 2025), $13.6 million (Q3 2024), and $46000.0 (Q1 2024), per Business Quant data.